PAVmed (PAVM) Depreciation & Amortization (CF) (2016 - 2025)

PAVmed's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $18000.0 for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 73.91% year-over-year to $18000.0; the TTM figure through Dec 2025 stood at $105000.0 (down 89.06% YoY), while the FY2025 annual figure was $105000.0, down 91.24% from the prior year.
• Depreciation & Amortization (CF) was $18000.0 for Q4 2025 at PAVmed, down from $22000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $815000.0 in Q2 2022 to a low of $10000.0 in Q2 2021.
• Historically, Depreciation & Amortization (CF) has averaged $351263.2 across 5 years, with a median of $216000.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 8050.0% in 2022, then tumbled 92.79% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $166000.0 in 2021, then surged by 337.35% to $726000.0 in 2022, then decreased by 0.14% to $725000.0 in 2023, then slumped by 90.48% to $69000.0 in 2024, then tumbled by 73.91% to $18000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $18000.0 (Q4 2025), $22000.0 (Q3 2025), and $22000.0 (Q2 2025), per Business Quant data.